EPO and chronic kidney disease: Though speculative, it may reflect a direct effect of uremia on NfL levels through reductions in neuroprotective molecules, such as erythropoietin and vitamin D,6 or through comorbid conditions common to CKD that also affect NfL levels, such as diabetic peripheral neuropathy and cerebrovascular disease.36